46
Pharma & HealthcareHold
ABSL Pharma And Healthcare
Aditya Birla Sun Life · Direct–Growth · rank #10 of 18 by Smart Score
Data updated
Trailing returns
1 Year
20.3%
+17.2% vs index
3 Years
23.0%
+11.4% vs index
5 Years
14.4%
+4.0% vs index
Since launch
21.7%
Year-by-year performance
2021
+21.4%-9.3% vs index
2022
-11.3%-15.1% vs index
2023
+39.6%+13.0% vs index
2024
+37.7%+22.0% vs index
2025
-3.1%-10.8% vs index
2026
+20.5%+22.6% vs index
Why this score
ABSL Pharma And Healthcare scores 46/100 — #10 of 18 Pharma & Healthcare fund (Hold). It stands out for sortino ratio — beating 77% of peers on sortino ratio. The main drag is its 5y return (better than only 28% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
5Y return14.41% · 28th percentile in category
Alpha3.06 · 16th percentile in category
Sortino ratio1.86 · 77th percentile in category
Sharpe ratio1.15 · 59th percentile in category
Volatility16.21 · 41st percentile in category
Expense ratio1.01% · 58th percentile in category
Top holdings
1.Torrent Pharmaceuticals Ltd9.94%
2.Sun Pharmaceutical Industries Ltd9.75%
3.Apollo Hospitals Enterprise Ltd7.08%
4.Cipla Ltd4.56%
5.Aurobindo Pharma Ltd4.29%
38 disclosed equity positions · portfolio as of Jul 2026 · weights are % of total corpus.